Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer

Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer

Triple-negative breast cancer (TNBC) is a highly heterogeneous disease defined by the absence of estrogen receptor (ER) and progesterone receptor (PR) expression, and human epidermal growth factor receptor 2 (HER2) overexpression that lacks targeted treatments, leading to dismal clinical outcomes. T...

Full description

Bibliographic Details
Main Authors:	Miquel Ensenyat-Mendez, Pere Llinàs-Arias, Javier I. J. Orozco, Sandra Íñiguez-Muñoz, Matthew P. Salomon, Borja Sesé, Maggie L. DiNome, Diego M. Marzese
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Oncology
Subjects:	triple-negative breast cancer TNBC molecular subtype of breast cancer epigenetics clustering artificial intelligence-AI
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.681476/full

Similar Items

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01)

Correlation between the CEM imaging characteristics and different molecular subtypes of breast cancer
by: Na Li, et al.
Published: (2023-12-01)

Outcome of Triple Negative Breast Cancer(TNBC) as compared to other breast cancers in Bir Hospital, National Academy of Medical Sciences
by: Anip Joshi, et al.
Published: (2024-11-01)

Rarest of the rare-male triple negative breast cancer
by: Haneesha Polavarapu, et al.
Published: (2022-01-01)

A Clinicopathological Analysis of Molecular Subtypes of Breast Cancer using Immunohistochemical Surrogates: A 6-Year Institutional Experience from a Tertiary Cancer Center in North India
by: Puneet Kaur Somal, et al.
Published: (2023-04-01)

New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer
by: Brahim El Hejjioui, et al.
Published: (2023-06-01)

Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
by: David P. Hill, et al.
Published: (2019-11-01)

Single-Cell Transcriptome Analysis Revealed Heterogeneity and Identified Novel Therapeutic Targets for Breast Cancer Subtypes
by: Radhakrishnan Vishnubalaji, et al.
Published: (2023-04-01)

USP22 supports the aggressive behavior of basal-like breast cancer by stimulating cellular respiration
by: Evangelos Prokakis, et al.
Published: (2024-02-01)

Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients
by: Pooja M. Vaid, et al.
Published: (2022-11-01)

The application of exosomes in the treatment of triple-negative breast cancer
by: John W. Weaver, et al.
Published: (2022-11-01)

Subtypes of breast cancer
by: D. D. Pak, et al.
Published: (2014-07-01)

Breast Cancer in Patients with Previous Endometriosis Showed Low Aggressive Subtype
by: Gianluca Vanni, et al.
Published: (2024-04-01)

Unraveling the protein kinase C/NDRG1 signaling network in breast cancer
by: C. Saponaro, et al.
Published: (2024-12-01)

The Impact of Subtype Distribution in Inflammatory Breast Cancer Outcome
by: Burcu Çakar, et al.
Published: (2018-10-01)

LRP-1 Matricellular Receptor Involvement in Triple Negative Breast Cancer Tumor Angiogenesis
by: Océane Campion, et al.
Published: (2021-10-01)

Editorial: Recent advancements in neoadjuvant chemotherapy for specific breast cancer subtypes
by: Sirin A. Adham, et al.
Published: (2022-12-01)

Effects of Garlic on Breast Tumor Cells with a Triple Negative Phenotype: Peculiar Subtype-Dependent Down-Modulation of Akt Signaling
by: Federica Brugnoli, et al.
Published: (2024-05-01)

Classifying Breast Cancer Metastasis Based on Imaging of Tumor Primary and Tumor Biology
by: Barbara Awad, et al.
Published: (2023-01-01)

iGlioSub: an integrative transcriptomic and epigenomic classifier for glioblastoma molecular subtypes
by: Miquel Ensenyat-Mendez, et al.
Published: (2021-08-01)

A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype
by: Zihao Chen, et al.
Published: (2021-09-01)

MYC-Driven Pathways in Breast Cancer Subtypes
by: Yassi Fallah, et al.
Published: (2017-07-01)

Metabolic Health, Insulin, and Breast Cancer: Why Oncologists Should Care About Insulin
by: Lisa D. Yee, et al.
Published: (2020-02-01)

Immune Landscape of Breast Cancers
by: Divya Nagarajan, et al.
Published: (2018-02-01)

Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya
by: Rispah T. Sawe, et al.
Published: (2017-08-01)

Identification of hub genes and diagnostic efficacy for triple-negative breast cancer through WGCNA and Mendelian randomization
by: Yilong Lin, et al.
Published: (2024-04-01)

NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer
by: Margherita Sonnessa, et al.
Published: (2020-09-01)

Rationally Designed Ruthenium Complexes for Breast Cancer Therapy
by: Golara Golbaghi, et al.
Published: (2020-01-01)

DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells
by: Stella C. Ogbu, et al.
Published: (2021-12-01)

Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes
by: Trygve Lofterød, et al.
Published: (2018-06-01)

Molecular profiling of breast cancer methylation pattern in triple negative versus non- triple negative breast cancer
by: Marwa Mohanad, et al.
Published: (2025-02-01)

Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer
by: Natalia Paez Arango, et al.
Published: (2017-08-01)

Molecular breast cancer subtypes prevalence in an indigenous Sub Saharan African population
by: Moses Galukande, et al.
Published: (2014-04-01)

Mammographic density and its association with molecular subtype of breast cancer.
by: Naila Jabeen, et al.
Published: (2020-12-01)

The neoepitope landscape of breast cancer: implications for immunotherapy
by: Pooja Narang, et al.
Published: (2019-03-01)

In vitro anticancer efficacy of a polyphenolic combination of Quercetin, Curcumin, and Berberine in triple negative breast cancer (TNBC) cells
by: Akanksha Kashyap, et al.
Published: (2022-05-01)

The role of biomarkers in the early diagnostics of breast cancer
by: A. Kh. Ismagilov, et al.
Published: (2021-03-01)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
by: Dey Nandini, et al.
Published: (2021-05-01)

Clinical and Subtypes of Breast Cancer in Indonesia
by: I Ketut Widiana, et al.
Published: (2020-12-01)

Triple-negative breast cancer: from none to multiple therapeutic targets in two decades
by: Filomena Marino Carvalho
Published: (2023-11-01)